Media & Investors

Corporate Profile

Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule oncology drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment.

Stock Quote

Volume:

Copyright Nasdaq. Minimum 15 minutes delayed.

In the Media

Jun 29, 2016
Source
BioCentury

Upcoming Events

More events are coming soon.